ScienceDaily (Sep. 18, 2008) — In a study published this week in PLoS Biology, Eric Xu and colleagues have determined the molecular structure of a nuclear receptor, which regulates the expression of specific genes within cells, that may serve as a drug target for diseases related to heart and blood vessel development, human embryonic development and female infertility. Researchers also found that the receptor, named COUP-TFII, is activated by retinoic acid, a form of Vitamin A.

"Not only does the structural information provide a basis for drug design in any diseases that COUP-TFII plays a role in, but it also can provide insight into the entire subfamily of receptors that COUP-TFII belongs to, which could have implications for additional associated diseases," said Xu, who heads the laboratory that published the findings.

The researchers determined the molecular structure of COUP-TFII through X-ray crystallography, which involved purifying the protein, growing crystals, directing X-rays at the crystals, and using the resulting information to determine the structure. Structural information can help drug developers fit therapeutics more perfectly to the receptors they bind to for maximum potency and can also aid in manipulating drugs to produce fewer side effects.

The findings could also have implications for cancer therapy. "Since COUP-TFII plays a role in embryonic blood vessel development, it might play a similar role in tumors and cancer growth," said Schoen Kruse, lead author of the study. "Formation of new blood supply in tumors is a stepping stone in the ability of cancers to grow and metastasize within the body."

The signal-triggering molecules known as ligands, which activate nuclear receptors have been discovered for most receptors, but not for a subset of "orphan" nuclear receptors whose ligand remains unknown. The study's finding that COUP-TFII is activated by retinoic acid is significant since the receptor previously belonged to this subset of "orphan" receptors.

Journal reference:

1. Kruse SW, Suino-Powell K, Zhou XE, Kretschman JE, Reynolds R, et al. Identification of COUP-TFII Orphan Nuclear Receptor as a Retinoic Acid%u2013Activated Receptor. PLoS Biol, 2008; 6(9): e227 DOI: 10.1371/journal.pbio.0060227

Email or share this story:  

Related Stories

Hormone Control Of Rare Leukemia Sheds Light On Molecular Basis Of Cancer (Feb. 24, 1998) — Often in science it's the exception that illuminates the rule. Thus, when researchers at the University of Pennsylvania Medical Center clarified the biochemical mechanism behind acute ...  > read more

Opposing Fat Metabolism Pathways Triggered By A Single Gene (Feb. 13, 2005) — In the premier open-access journal PLoS Biology, Keith Yamamoto and colleagues show that the nuclear hormone receptor nhr-49 controls two different aspects of fat metabolism, which interact to form a ...  > read more

UV Radiation Induces Vitamin A Deficiency In Skin (Mar. 31, 1999) — That golden tan may look terrific, but its cost to your skin---premature aging, wrinkles, sags, blotches, and an increased risk of skin cancer---may be more than you want to pay. While it is well ...  > read more

Repressor Protein Blocks Neural Stem Cell Development (Oct. 12, 2007) — A protein known to repress gene transcription at the molecular level in a variety of processes also blocks embryonic neural stem cells from differentiating into neurons, according to a new ...  > read more

Search ScienceDaily

Doggy Genes